OPA1 (Optic Atrophy Protein 1), a mitochondria-shaping protein, participates in resistance against gefitinib in a lung adenocarcinoma cell line [22] and cisplatin in NSCLC [23]. Here, PROS1 is linked to lung adenocarcinoma.